23andMe has engaged in corporate venture investment activity by making two investments in companies: Halo and Orchid. Additionally, the company has acquired two other companies, Icebreaker Health and CureTogether.
55% of their portfolio is in Healthcare. Average disclosed round size is $56.3M (across 10 rounds with reported amounts).
Portfolio
11
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
11 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Volta Labs | Series A | $20M | Mar 2022 |
 Getlabs | Series A | $20M | Feb 2022 |
 Apeel Sciences | Series E | $250M | Aug 2021 |
 ixlayer | Series A | $75M | Mar 2021 |
 Base | Seed | $3.4M | Feb 2021 |
 ThirdLove | Series C | $55M | Feb 2019 |
 Doctor On Demand | Series B | $50M | Jun 2015 |
 Orchid | Series A | $12M | — |
 Multiverse | Series B | $44M | — |
 Call9 | Unknown | — | — |
| Call9 | Series B | $34M | — |
Top Co-Investors
YouTube3 shared
General Catalyst2 shared
Index Ventures2 shared
Y Combinator2 shared
Figma1 shared
Coinbase Ventures1 shared
Female Founders Fund1 shared
TheVentureCity1 shared
Brooklyn Bridge Ventures1 shared
Amplifyher Ventures1 shared
Maverick Ventures1 shared
Khosla Ventures1 shared
Casdin Capital1 shared
E14 Fund1 shared
Illumina Ventures1 shared
Emerson Collective1 shared
GV (Google Ventures)1 shared
Audacious Ventures1 shared
Latitude1 shared
Semper Virens1 shared
Last updated: 16 April 2026